Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Lominska, Chris E ^a   Unger, Keith ^b   Nasr, Nadim M ^c   Haddad, Nadim ^b   Gagnon, Greg ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c VIRGINIA HOSPITAL CENTER   (United States)

Author keywords

Pancreatic cancer; Radiotherapy; Reirradiation; SBRT

Indexed keywords

CAPECITABINE; FLUOROURACIL; GEMCITABINE; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTESTINE OBSTRUCTION; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; RADIATION DOSE FRACTIONATION; RADIATION INDUCED EMESIS; RADIATION SICKNESS; RECURRENT CANCER; RETROSPECTIVE STUDY; SALVAGE THERAPY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE; ADENOCARCINOMA; ADJUVANT THERAPY; EVALUATION; METHODOLOGY; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; RADIATION DOSE; RADIOSURGERY; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIATION DOSAGE; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84861127528     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-74     Document Type: Article

References (22)

1. Griffin JF, Smalley SR, Jewell W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990, 66:56-61. 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6, 2354408.
2. Tepper J, Nardi G, Sutt H. Carcinoma of the pancreas: review of MGH experience from 1963 to 1973, Analysis of surgical failure and implications for radiation therapy. Cancer 1976, 37:1519-1524. 10.1002/1097-0142(197603)37:3<1519::AID-CNCR2820370340>3.0.CO;2-O, 1260670.
3. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985, 120:899-903. 10.1001/archsurg.1985.01390320023003, 4015380.
4. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004, 350:1200-1210. 10.1056/NEJMoa032295, 15028824.
5. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999, 230:776-782. discussion 782-774, 10.1097/00000658-199912000-00006, 1420941, 10615932.
6. Garofalo MC, Regine WF, Tan MT. On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer. Ann Surg 2006, 244:332-333. author reply 333, 10.1097/01.sla.0000229980.81505.44, 1602155, 16858208.
7. Martin A, Gaya A. Stereotactic Body Radiotherapy: A Review. Clin Oncol (R Coll Radiol) 2010, 22:157-172.
8. Koong AC, Christofferson E, Le QT, et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2005, 63:320-323. 10.1016/j.ijrobp.2005.07.002, 16168826.
9. Adler JR, Chang SD, Murphy MJ, et al. The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg 1997, 69:124-128. 10.1159/000099863, 9711744.
10. Pishvaian AC, Collins B, Gagnon G, et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 2006, 64:412-417. 10.1016/j.gie.2006.01.048, 16923491.
11. Shaw E, Kline R, Gillin M, et al. Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 1993, 27:1231-1239. 10.1016/0360-3016(93)90548-A, 8262852.
12. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007, 297:267-277. 10.1001/jama.297.3.267, 17227978.
13. Regine WF, Winter KA, Abrams RA, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 2008, 299:1019-1026. 10.1001/jama.299.9.1019, 18319412.
14. Loehrer PJ, Powell ME, Cardenes HR, et al. A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer. J Clin Oncol 2011, 29:4105-4112. 10.1200/JCO.2011.34.8904, 21969502.
15. Chang DT, Schellenberg D, Shen J, et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 2009, 115:665-672. 10.1002/cncr.24059, 19117351.
16. Koong AC, Le QT, Ho A, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004, 58:1017-1021. 10.1016/j.ijrobp.2003.11.004, 15001240.
17. Schellenberg D, Goodman KA, Lee F, et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2008, 72:678-686. 10.1016/j.ijrobp.2008.01.051, 18395362.
18. Hoyer M, Roed H, Sengelov L, et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005, 76:48-53. 10.1016/j.radonc.2004.12.022, 15990186.
19. Mahadevan A, Jain S, Goldstein M, et al. Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys 2010, 78:735-742. 10.1016/j.ijrobp.2009.08.046, 20171803.
20. Rwigema JC, Parikh SD, Heron DE, et al. Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas. Am J Clin Oncol 2011, 34:63-69. 10.1097/COC.0b013e3181d270b4, 20308870.
21. Seo Y, Kim M, Yoo S, et al. Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys 2009, 75:1456-1461. 10.1016/j.ijrobp.2009.01.042, 19783379.
22. Schellenberg D, Quon A, Minn AY, et al. (18)Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy. Int J Radiat Oncol Biol Phys 2010, 77:1420-1425. 10.1016/j.ijrobp.2009.06.049, 20056345.